Bentleys Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 28-06-2024
- Paid Up Capital ₹ 0.41 M
as on 28-06-2024
- Company Age 38 Year, 7 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 1.16 M
as on 28-06-2024
- Satisfied Charges ₹ 10.13 Cr
as on 28-06-2024
- Revenue %
(FY 2019)
- Profit 23.37%
(FY 2019)
- Ebitda 23.37%
(FY 2019)
- Net Worth -2.73%
(FY 2019)
- Total Assets -2.69%
(FY 2019)
About Bentleys Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.41 M.
The company currently has active open charges totaling ₹1.16 M. The company has closed loans amounting to ₹10.13 Cr, as per Ministry of Corporate Affairs (MCA) records.
Srivatsan and Sankar Ramamurthy serve as directors at the Company.
- CIN/LLPIN
U24231TN1986PTC012992
- Company No.
012992
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 May 1986
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bentleys Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srivatsan  | Additional Director | 02-Mar-2020 | Current |
| Sankar Ramamurthy | Director | 09-Jul-2010 | Current |
Financial Performance of Bentleys Pharmaceuticals.
Bentleys Pharmaceuticals Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 23.37% increase in profit. The company's net worth dipped by a decrease of 2.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bentleys Pharmaceuticals?
In 2019, Bentleys Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shriram Engineering Products Private LimitedActive 36 years 2 monthsSankar Ramamurthy is a mutual person
- Shriram Automall Land Holdings Private LimitedActive 15 years 9 months
Sankar Ramamurthy is a mutual person
- Shriram Properties Holdings Private LimitedActive 14 years 7 months
Sankar Ramamurthy is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 01 Apr 2001 | ₹0.15 M | Open |
City Union Bank Ltd Creation Date: 20 Apr 1993 | ₹0.96 M | Open |
Canara Bank Creation Date: 21 Oct 1986 | ₹0.05 M | Open |
How Many Employees Work at Bentleys Pharmaceuticals?
Unlock and access historical data on people associated with Bentleys Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bentleys Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bentleys Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
